Menarini Progresses Into the Clinic With MEN1611, a PI3K Inhib...
POMEZIA, Italy, October 19, 2018 /PRNewswire-AsiaNet/ -- Menarini Ricerche announced today the initiation of the B-PRECISE-01 clinical trial, a multicenter phase Ib study that will evaluate the safety and efficacy of MEN1611 plus trastuzumab with or without fulvestrant. The study will enroll patients wi...
Read more https://view-release/?pr-id=75795